A clinical study to assess the effect of Nasal therapy using medicated ghee in patients with hair fall.

A Single Arm Clinical Trial to Evaluate the Keratinocyte Proliferative Effect of Nasya Karma with Triphala Ghritam using Keratinocyte Growth Factor Biomarker in patients with Khalitya. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104889

Enrollment

Registered

2026-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L659- Nonscarring hair loss, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Those having hairfall greater than 150 strands per day 2. Age (18-40 years) 3. Nasya Arha

Exclusion criteria

Exclusion criteria: - Nasya Anarha - Active scalp infections, Acne. - Post partum, pregnant, lactating women. - Patients undergoing hormonal replacement therapy or Immunosuppressive therapy. - H/O Nasal Disorders like polyps, chronic sinusitis, deviated nasal septum with obstruction. - Systemic illnesses: Diabetes mellitus, Thyroid, hepatic, renal or cardiac diseases. - Under psychiatric medication. - H/o topical hair growth treatments done in the past one month. - Alopecia areata, alopecia totalis.

Design outcomes

Primary

Measure	Time frame
To assess the Improvement in hair density and scalp by visual analysis of hair and scalp.Timepoint: Day 0, Day 30	—

Secondary

Measure	Time frame
To assess an increase in Keratinocyte proliferation after Nasya karma with Triphala ghritam.Timepoint: Day 0, Day 8, Day 15	—

Countries

India

Contacts

Public ContactDr K P Namboothiri

Amrita School of Ayurveda

kadambaripb@gmail.com9746004107

Outcome results